Stay updated on Durvalumab Consolidation in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.

Latest updates to the Durvalumab Consolidation in NSCLC Clinical Trial page
- CheckyesterdayChange DetectedA new Study Status entry was added on 2026-02-10 and an earlier entry was removed on 2025-11-10 in the record history.SummaryDifference0.2%

- Check8 days agoChange DetectedThe new version adds multiple study locations (and their contacts) and removes several previously listed locations. This updates the geographic coverage and contact points shown in the study record.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page history shows a new revision label (v3.4.2) replacing v3.4.1, a minor site update that does not affect study data or user-facing content; to avoid alerts for small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed; no substantive content changes to the study record are visible.SummaryDifference0.1%

- Check36 days agoChange DetectedUI updates add a glossary toggle, color-coded diff highlights (green for additions, red for deletions), and a revision label (v3.4.0) with minor capitalization tweaks; the underlying study history content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check50 days agoChange DetectedNew revision entry v3.3.4 was added to the history, replacing the previous v3.3.3.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Consolidation in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.